Geriatric care is increasingly complex due to the interplay of multiple organ-system pathologies, age-related physiological changes, and multimorbidity. This review synthesizes current evidence on the integrated management of older adults across organ-system boundaries, emphasizing mechanisms, risk stratification, clinical features, and the latest advances in diagnosis and treatment. A focus on guideline recommendations and practical strategies is presented to optimize outcomes for an aging population, with a view toward future directions in geriatric medicine.
The global rise in the elderly population necessitates a paradigm shift in medical care that transcends traditional organ-based specialties. Geriatric patients frequently present with overlapping diseases, atypical symptomatology, and functional decline, challenging clinicians to adopt a holistic, systems-based approach. This article reviews the epidemiology, pathophysiology, and management strategies required for comprehensive geriatric care across organ-system boundaries, integrating recent research, clinical guidelines, and practical insights to inform best practices.
The prevalence of multimorbidity defined as the coexistence of two or more chronic conditions in adults over 65 exceeds 60% in developed nations. Cardiovascular disease, diabetes, chronic kidney disease, neurodegenerative disorders, and musculoskeletal degeneration often coexist, with each condition influencing the expression and progression of the others. Polypharmacy, hospital readmissions, and increased healthcare utilization are common, reflecting the substantial societal and economic burden of complex geriatric care. The World Health Organization projects that by 2050, 1 in 6 people globally will be aged over 65, underscoring the urgency for integrated, organ-system-spanning approaches.
Age-related physiological changes such as reduced renal clearance, diminished cardiac reserve, altered immune function, and neuroendocrine dysregulation contribute to atypical disease presentation and increased susceptibility to adverse outcomes. Cross-talk between organ systems is mediated by systemic inflammation, oxidative stress, and hormonal shifts; for example, heart failure exacerbates renal dysfunction (cardiorenal syndrome), while diabetes accelerates microvascular and macrovascular complications affecting multiple organ systems. Sarcopenia, frailty, and cognitive impairment further compromise homeostasis and recovery potential in older adults.
Major risk factors for adverse geriatric outcomes include advancing age, polypharmacy, frailty, cognitive impairment, sensory deficits, malnutrition, and limited social support. Genetic predispositions, prior organ dysfunction, and environmental exposures also contribute. Importantly, iatrogenic risks such as drug interactions, procedural complications, and hospital-acquired infections are heightened due to decreased physiological reserve and multi-system vulnerability.
Geriatric syndromes often present with non-specific or atypical symptoms. For instance, infection may manifest as delirium rather than fever; myocardial infarction may present as syncope or breathlessness instead of chest pain. Overlapping manifestations such as falls, incontinence, weight loss, and functional decline frequently reflect underlying multi-organ pathology. Comprehensive assessment tools (e.g., Comprehensive Geriatric Assessment, or CGA) are pivotal for identifying subtle clinical cues and guiding multidisciplinary intervention.
Diagnosis in geriatric medicine demands thorough history-taking, collateral information, and the use of validated screening instruments. Laboratory and imaging findings may be masked or altered by age-related changes and polypharmacy. Multidimensional tools such as the CGA, Mini-Mental State Examination, and frailty indices enable risk stratification and inform individualized care plans. Interdisciplinary collaboration is essential for differentiating between acute, reversible conditions and chronic, progressive disease processes.
Optimal management requires balancing disease-specific interventions with the overall goals of care, functional status, and patient preferences. Polypharmacy should be minimized through regular medication review and deprescribing where appropriate. Non-pharmacological interventions such as nutritional support, physical rehabilitation, and cognitive stimulation are integral. Coordination between primary care, specialty services, nursing, and social work ensures continuity and addresses social determinants of health. Advanced care planning and shared decision-making are vital, particularly in the context of limited life expectancy or advanced frailty.
Recent advances include the use of artificial intelligence for risk prediction, telemedicine for remote monitoring, and novel biomarkers for early detection of organ dysfunction. Multimodal interventions targeting frailty, such as resistance exercise combined with protein supplementation, show promise in improving outcomes. Pharmacogenomic approaches are being explored to optimize drug selection and dosing in the elderly. Interdisciplinary geriatric care models, such as Acute Care for Elders (ACE) units, have demonstrated reduced hospitalization and improved functional outcomes.
Major organizations, including the American Geriatrics Society and NICE, recommend individualized care plans, regular medication review, and the use of CGA for complex elderly patients. Guidelines emphasize minimizing potentially inappropriate medications (e.g., as per the Beers Criteria), optimizing chronic disease control without overtreatment, and prioritizing functional independence. Early involvement of palliative care is advocated for those with advanced illness or refractory symptoms. Integration of multidisciplinary teams and shared decision-making is consistently highlighted across guidelines.
Geriatric care across organ-system boundaries requires a nuanced, integrative approach that accounts for the interplay of multiple pathologies, age-related changes, and patient-centered goals. Recent advances in diagnostics, therapeutics, and care delivery models offer new opportunities for improving quality of life and clinical outcomes in older adults. Ongoing research, education, and system-level innovation remain essential to meet the growing demands of geriatric populations worldwide.
1.
"Unusual" Cancers Following Pandemic; Triumph in TNBC; Clinical Trial Interrupted by Shortage.
2.
Recently released national data on drug use and abuse among Americans.
3.
Despite Medicare Coverage, Cancer Genomic Testing Still Low
4.
Ketamine plus psychotherapy for "excellent" PTSD
5.
Psychedelic Therapy Tied to Reduced Depression, Anxiety.
1.
Personalized Tumor Ecological Landscapes in Oncology
2.
Unlocking the Potential of Glofitamab: A Novel Treatment for Cancer
3.
Preserving Social Identity During Cancer Survivorship
4.
Battling Blood Cancers: Advances in HIV-Related Hematologic Malignancies in the ART Era
5.
Regenerative Models of Tumor Microenvironments: Clinical Relevance and Emerging Insights
1.
International Conference on Cancer Nursing and Rehabilitation Strategies
2.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
3.
International Conference on Innovations in Critical Care for Oncology and Cardiology
4.
International Symposium on Oncology, Cardiology and Critical Care Innovations
5.
International Conference on Cancer Nursing and Hematology Support
1.
An Intro to The Multifaceted Advantages of CDK4/6 Inhibitors in HR+/HER2- Advanced Breast Cancer Clinical Studies.
2.
Dacomitinib Case Presentation: Baseline Treatment and Current Status
3.
Advances in Classification/ Risk Stratification of Plasma Cell Dyscrasias- The Summary
4.
From Guidelines to Practice: Hematology
5.
Breast Cancer Awareness and Early Detection
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation